This Supporting Information contains additional discussion on the chromatographic conditions that were used in this study, including some examples of typical chromatograms.
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Chromatographic conditions and results. Samples containing 10 μM of the desired drug or a mixture of 10 μM drug and 20 μM soluble HSA were injected at the following flow rates, as determined by the degree of retention for each drug on the microcolumns and their rate of dissociation from soluble HSA: acetohexamide, 0.5-2.75 mL/min; chlorpromazine, 0.5-2.0 mL/min; gliclazide, 0.25-3.0 mL/min; tolbutamide, 0.25-2.5 mL/min; verapamil, 0.25-2.5 mL/min; and warfarin, 0.5-3.5 mL/min. The following wavelengths were employed for absorbance detection: acetohexamide, 248 nm; chlorpromazine, 254 nm; gliclazide, 226 nm; tolbutamide, 227 nm; verapamil, 229 nm; and warfarin, 308 nm.
Some typical chromatograms that were obtained in this study are shown in Figure 1S . Similar chromatograms were acquired for all of the drugs that were examined in this report. To generate these chromatograms, each drug was injected in either the presence or absence of excess soluble HSA onto an HSA microcolumn. As the sample passed through the microcolumn at a moderate-to-high flow rate, the protein-bound fraction of the drug and the excess soluble protein eluted as a non-retained peak while the free fraction of the drug was extracted, retained and later eluted from the column. Depending on the application flow rate, the non-retained peak eluted in 2 min or less. The retained peak for the free drug fraction eluted within 2-10 min of sample injection for all of the drugs that were studied, depending on the column size, degree of retention for the drug on the column and the injection flow rate. For drugs with low-to-moderate affinities for HSA, results were obtained within only 2-6 min. Figure S1 .
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Chromatograms obtained at various flow rates for 1 μL injections of 10 μM verapamil and 20 μM HSA onto a 10 mm × 2.1 mm i.d. HSA microcolumn at pH 7.4 and 37 C.
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Derivation of eq 4 and eq 5. The derivation of eqs 4 and 5 is based on the reaction model that is given in eq 3.
→
In this model, the observed rate of dissociation for the soluble complex AP is described by the rate expression in eq 1S and by the equivalent integrated forms of this expression in eqs 2S and 3S.
[
The term This is accomplished by using eqs 4S and 5S, in which [A] tot represents the total concentration of A in the original sample.
Substitution of eqs 4S and 5S into eqs 2S and 3S leads to the equivalent expressions in eqs 4 and 5 that can be used with ultrafast affinity extraction to provide information on the dissociation rate of A from P in the solution-phase sample. indicated that the method used in this report for dissociation rate constant measurements was robust and not affected significantly by changes in the sample concentrations under the conditions that were used in this study.
A similar conclusion was made when comparing the association equilibrium constants that were measured using different sample concentrations, as demonstrated in Table 1S . For instance, the K a that was estimated for warfarin was found in the range of 1.7-2.4 × 10 5 M -1 , under all of the tested sample conditions, in good agreement with reference values. S5,S6,S7 The K a for chlorpromazine that was in the range of 0.62-0.65 × 10 5 M -1 , also agreeing with prior values in the literature. S8 The nK a ' values for tolbutamide and acetohexamide were consistently in the range of 1.1 × 10 5 M -1 and 1.7-1.8 × 10 5 M -1 , respectively, as noted in prior work.
S9,S10 Table S1 also lists some of the free drug fractions that were measured or estimated to be present at equilibrium in each of the samples that were examined. These values, and those used in studying the other drugs that were considered in this work, covered a range of 25% to almost b These values for F0 were determined from the intercept of eq 5. The K a values in these cases were calculated based on eq 6 and these F0 values.
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Estimation of association rate constants. The K a and k d values that were determined in this study were used to estimate the second-order association rate constant (k a ) for each drug with soluble HSA, as based on the relationship k a = k d K a . The values that were used in these calculations and the resulting estimates of k a that were obtained are summarized in Table 2S .
The results for warfarin gave good agreement with previous k a values that have been reported for this drug with HSA at pH 7.4 and 37ºC. S1,S2,S3,S11 The k a values estimated for acetohexamide, tolbutamide, and racemic verapamil with HSA were similar to those obtained when using previously-reported k d and K a or nK a ' values for these same systems. S2,S4,S9,S10,S12 In addition, k a values found for gliclazide and chlorpromazine agreed with the range of k a value that have been noted in prior work for other drugs with similar association equilibrium constants and dissociation rate constants for HSA.
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